
#CAP podcast about the new HPV testing guideline for head and Cancer m.soundcloud.com/pathologist…

Surgical pathologist; Cytopathologist; Head & Neck Path; MGH & MEEI; Professor of Path Harvard Medical School; Bonsai enthusiast; Partner: Judson Evans (poet)

#CAP podcast about the new HPV testing guideline for head and Cancer m.soundcloud.com/pathologist…

#OpenAccess 🔓 With the Genius system for digital cytology, the sensitivity for HSIL+/ASC-H and the specificity for LSIL and HSIL were superior to liquid-based cytology and computer assistance. acsjournals.onlinelibrary.wi… #CytoPath CC: @bfaquin

With ROSE-guided molecular triage of EUS-sampled pancreatic cancer, 95% of tested cytology specimens gave reportable DNA NGS, and smears alone succeeded in 13/13 cases! Do you assess molecular adequacy at ROSE and sequence smears? @CancerCytopath @Sinchita_Roy @bfaquin
New and #OpenAccess! 🎯 Implementing a rapid on-site molecular adequacy protocol for EUS-guided PDAC samples can achieve high success rates for DNA-based NGS. However, intrinsic low tumor cellularity may limit adequacy. 🔗: acsjournals.onlinelibrary.wi… #CytoPath @Sinchita_Roy

Learn about some key thyroid cytology issues in this American Cancer Society podcast ! cancerspeak.podbean.com/e/ta… @CancerCytopath @JournalCancer @ZMaleki_cyto @IvanaKholova @MGBpathology @Gloria_SuraMD

Free to access! 🔓 DICER1-mutant nodules are unlikely to be BRAF-mutant carcinomas, and further study will contribute to more accurate cytological diagnosis. acsjournals.onlinelibrary.wi… #CytoPath

Thank you Cancer Cytopathology for caffeinating me during the ASC mtg!!! 🤣 ☕️😍 ☕️


#ASCyto26 | At 8am this morning, @HeymannJonas leads the Digital Slide Workshop on Pancreatic Aspiration Cytology: An Algorithmic Approach to Morphology, Reporting, and Molecular and Other Ancillary Testing 🔬 Don't miss it! #CytoPath

New publication in Cancer Cytopathology! 🎉🇫🇮🇨🇿 Our Finnish–Czech collaboration on rare primary pulmonary salivary gland-type tumors: overall cytohistologic concordance 48.1%, with FNA performing best (75%). Many thanks to Henri Lagerstam & Ivana Kholová doi.org/10.1002/cncy.70153

#ASCyto26: Join Dr. Bill Faquin (@bfaquin) & Dr. Vanda Torous (@VandaTorousMD) today at 8am for Short Course 13, "Solving the Mystery: Metastatic Cancer of Unknown Primary in the Head and Neck." Revisit a related and fascinating case report: acsjournals.onlinelibrary.wi… #CytoPath

ICYMI: Tune in to this special #CytoChat edition of #CancerSpeak for a practical discussion of challenging thyroid FNA cases, from diagnostic pitfalls and mimics to molecular testing and more. 🔬 Listen below! @bfaquin @zmaleki_cyto #CytoPath #ASCyto26 cancerspeak.podbean.com/e/ta…

#ASCyto26 @MichiyaNishino presenting using WHO Reporting System for Head and Neck Cytology @CancerCytopath

@bfaquin presenting WHO reporting system for head and neck cytology (WHO-RSHNC) for non-squamous H&N lesions.
Coming up at #ASCyto26: Catch our EIC Dr. Bill Faquin (@bfaquin), Associate Editor Michiya Nishino (@MichiyaNishino), and Ed Board member Zubair Baloch (@aakasharmand) during Short Course 5 on The WHO Reporting System for H&N #CytoPath: Applications with Case Studies.

Thank you @CancerCytopath @bfaquin It is always wonderful to be recognized for doing something that you love doing. #CytoPath #cytology 🙏🏽#ASCyto26

Dr. Baloch discusses the new WHO System for Head and Neck cytology! #ASC

#ASCyto26 @bfaquin @CancerCytopath
@bfaquin presenting WHO reporting system for head and neck cytology (WHO-RSHNC) for non-squamous H&N lesions.